ArticleNPJ precision oncology2024

NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients.

Jean-Stéphane Giraud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.